Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

David T. Rubin,^a Russell D. Cohen,^a William J. Sandborn,^b Gary R. Lichtenstein,^c Jeffrey Axler,^d Robert H. Riddell,^e Cindy Zhu,^f Andrew C. Barrett,^f Enoch Bortey,^f William P. Forbes^f

^aInflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA ^bDivision of Gastroenterology, University of California [UC] San Diego and UC San Diego Health System, San Diego, CA, USA ^cDivision of Gastroenterology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA ^dToronto Digestive Disease Associates, Toronto, ON, Canada ^eDepartment of Pathology and Laboratory Medicine, Mt Sinai Hospital, Toronto, ON, Canada ^fSalix Pharmaceuticals, Raleigh, NC, USA

doi:10.1093/ecco-jcc/jjx032

This article has been updated to correct an error to the n value for patients randomised to treatment in Figure 1.